Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)

Current COVID-19 vaccines need to take at least one month to complete inoculation and then become effective. Around 51% of the global population is still not fully vaccinated. Instantaneous protection is an unmet need among those who are not fully vaccinated. In addition, breakthrough infections cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xilin, Wang, Yaxing, Cheng, Lin, Ni, Fengfeng, Zhu, Linjing, Ma, Sen, Huang, Bilian, Ji, Mengmeng, Hu, Huimin, Li, Yuncheng, Xu, Shijie, Shi, Haixia, Zhang, Doudou, Liu, Linshuo, Nawaz, Waqas, Hu, Qinxue, Ye, Sheng, Liu, Yalan, Wu, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967979/
https://www.ncbi.nlm.nih.gov/pubmed/35371009
http://dx.doi.org/10.3389/fimmu.2022.865401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967979/
https://www.ncbi.nlm.nih.gov/pubmed/35371009
http://dx.doi.org/10.3389/fimmu.2022.865401

Ejemplares similares